.:. Listes > Par auteur > Auclair .:.

15 documents classés par : Date Titre Nom du premier auteur Type de documents Date de dépôt

1 - 2

EWS-FLI1 inhibits TNFalpha-induced NFkappaB-dependent transcription in Ewing sarcoma cells. Lagirand-Cantaloube J., Laud K., Lilienbaum A., Tirode F., Delattre O., Auclair C., Kryszke M.-H. Biochemical and Biophysical Research Communications / Biochemistry and Biophysics Research Communications 399, 4 (2010) 705-10 [hal-00533833 - version 1]

The aberrant localization of oncogenic kit tyrosine kinase receptor mutants is reversed on specific inhibitory treatment. Bougherara H., Subra F., Crépin R., Tauc P., Auclair C., Poul M.-A. Molecular Cancer Research 7, 9 (2009) 1525-33 [hal-00421163 - version 1]

Masitinib (AB1010), a Potent and Selective Tyrosine Kinase Inhibitor Targeting KIT Dubreuil P., Letard S., Ciufolini M., Gros L., Humbert M., Castéran N., Borge L., Hajem B., Lermet A., Sippl W. et al PLoS ONE 4, 9 (2009) e7258 [inserm-00423392 - version 1]

Critical involvement of the ATM-dependent DNA damage response in the apoptotic demise of HIV-1-elicited syncytia. Perfettini J.-L., Nardacci R., Bourouba M., Subra F., Gros L., Séror C., Manic G., Rosselli F., Amendola A., Masdehors P. et al PLoS ONE 3, 6 (2008) e2458 [hal-00290695 - version 1]

REVERSION OF MALIGNANT PHENOTYPE WITH 9-HYDROXY ELLIPTICINE DERIVATIVES Auclair C., Polard V., Maksimenko A. V. (2007-11-29) WO/2007/135538 - France [hal-00264857 - version 1]

Assessment of cellular actin dynamics by measurement of fluorescence anisotropy Spitz J.-A., Polard V., Maksimenko A. V., Subra F., Baratti-Elbaz C., Méallet-Renault R., Pansu R. B., Tauc P., Auclair C. Analytical Biochemistry 367 (2007) 95-103 [hal-00162079 - version 1]

METHODE D'IDENTIFICATION DE COMPOSES ACTIFS SUR LA REPLICATION DU VIRUS HIV Auclair C., Subra F., Mouscadet J.-F., Polard V. (2005-11-03) WO/2005/103654 - France [hal-00281628 - version 1]

The actin cytoskeleton-associated protein zyxin acts as a tumor suppressor in Ewing tumor cells. Amsellem V., Kryszke M.-H., Hervy M., Subra F., Athman R., Leh H., Brachet-Ducos C., Auclair C. Experimental Cell Research 304, 2 (2005) 443-56 [hal-00208001 - version 1]

UTILISATION D'INHIBITEURS ET D'OLIGONUCLEOTIDES ANTI-SENS DE LA BTK DANS LE TRAITEMENT DES MASTOCYTOSES PROLIFERATIVES Use of inhibitors and antisense oligonucleotides of BTK for treating proliferative mastocytosis. Auclair C., Subra F. (2004-11-03) WO/2004/096253 - France [hal-00211714 - version 1]

Mechanism of HIV-1 integrase inhibition by styrylquinoline derivatives in vitro. Deprez E., Barbe S., Kolaski M., Leh H., Zouhiri F., Auclair C., Brochon J.-C., Le Bret M., Mouscadet J.-F. Molecular Pharmacology 65, 1 (2004) 85-98 [hal-00247990 - version 1]